(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine...
Stats | |
---|---|
Dagens volum | 183 338 |
Gjennomsnittsvolum | 460 969 |
Markedsverdi | 16.32M |
EPS | $0 ( 2024-04-01 ) |
Neste inntjeningsdato | ( $-0.530 ) 2024-05-20 |
Last Dividend | $0.250 ( 2012-04-02 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.100 |
ATR14 | $0.00600 (1.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-07-27 | Dewilde Michel | Buy | 35 000 | Option (Right to Buy Common Shares) |
2023-07-27 | Braga Damian | Buy | 35 000 | Option (Right to Buy Common Shares) |
2023-07-27 | Baxter Jeff | Buy | 70 000 | Option (Right to Buy Common Shares) |
2023-07-27 | Cordeiro Joanne | Buy | 35 000 | Option (Right to Buy Common Shares) |
2023-07-27 | Beattie Nell | Buy | 52 500 | Option (Right to Buy Common Shares) |
INSIDER POWER |
---|
-68.18 |
Last 96 transactions |
Buy: 56 847 323 | Sell: 16 390 901 |
Volum Korrelasjon
VBI Vaccines Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
KRON | 0.879 |
VTSI | 0.868 |
RUBY | 0.866 |
ALVR | 0.862 |
ICCC | 0.849 |
PSTV | 0.84 |
LSBK | 0.828 |
GREE | 0.827 |
POWW | 0.827 |
PAIC | 0.826 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
VBI Vaccines Inc Korrelasjon - Valuta/Råvare
VBI Vaccines Inc Økonomi
Annual | 2023 |
Omsetning: | $8.68M |
Bruttogevinst: | $-5.82M (-66.98 %) |
EPS: | $-5.96 |
FY | 2023 |
Omsetning: | $8.68M |
Bruttogevinst: | $-5.82M (-66.98 %) |
EPS: | $-5.96 |
FY | 2022 |
Omsetning: | $1.08M |
Bruttogevinst: | $-10.19M (-942.14 %) |
EPS: | $-16.37 |
FY | 2021 |
Omsetning: | $631 000 |
Bruttogevinst: | $-10.14M (-1 606.81 %) |
EPS: | $-0.270 |
Financial Reports:
No articles found.
VBI Vaccines Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.250 | 2003-12-18 |
Last Dividend | $0.250 | 2012-04-02 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $1.250 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.23 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2003 | $0.250 | 14.60% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0.750 | 16.50% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0.250 | 0.02% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -11.81 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -1.179 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -5.05 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.478 | 0.800 | -2.61 | -2.09 | [1 - 3] |
quickRatioTTM | 0.329 | 0.800 | -2.77 | -2.21 | [0.8 - 2.5] |
cashRatioTTM | 0.313 | 1.500 | 9.37 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.610 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -17.68 | 1.000 | -7.66 | -7.66 | [3 - 30] |
operatingCashFlowPerShareTTM | -2.51 | 2.00 | -0.838 | -1.676 | [0 - 30] |
freeCashFlowPerShareTTM | -2.55 | 2.00 | -1.275 | -2.55 | [0 - 20] |
debtEquityRatioTTM | 7.05 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.496 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -9.09 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.134 | 1.000 | -7.41 | -7.41 | [0.2 - 2] |
assetTurnoverTTM | 0.0998 | 0.800 | -2.67 | -2.13 | [0.5 - 2] |
Total Score | -4.67 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.134 | 1.000 | -0.115 | 0 | [1 - 100] |
returnOnEquityTTM | -5.05 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -2.55 | 2.00 | -0.850 | -2.55 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -2.51 | 2.00 | -0.838 | -1.676 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00180 | 1.500 | -3.32 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -6.93 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.85 |
VBI Vaccines Inc
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.